Neurocrine Biosciences · 1 month ago
Public Policy Intern
Neurocrine Biosciences is a leading neuroscience-focused biopharmaceutical company dedicated to relieving suffering for people with great needs. The Public Policy Intern will gain experience in public policy issues affecting biopharmaceutical companies, conduct research, prepare summaries, and collaborate with various stakeholders within the company.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Conduct research on public policy issues relevant to Neurocrine and its stakeholders, including drug pricing reform (e.g., implementation of the Inflation Reduction Act, foreign reference pricing, state Prescription Drug Affordability Boards, etc.), the Medicare Part D and Medicaid programs, mental health policy, among others
Prepare summaries and presentations on specific research findings and present those to Public Policy, Government Affairs, Corporate Affairs, and others, as appropriate
Interact with multiple stakeholders within the company, particularly across Corporate Affairs
Collaborate with a mentor team of cross-functional members, as well as the other interns in the class
Complete one or more special projects and present the recommendations upon completion
Qualification
Required
Currently pursuing an undergraduate degree; preferably in one of the following fields: public health, public policy, political science/government, biotechnology/life sciences
A strong interest in public policy issues relevant to biotechnology and pharmaceuticals; prior experience in the pharmaceutical or biotechnology industry is an asset but is not required
Outstanding research and verbal and written communication skills
Ability to think creatively and be a team player within a high-functioning, fast-paced environment
Exhibit flexibility with a willingness to work on multiple projects simultaneously
Ability to commit to a 10-week, full-time summer program based in Neurocrine's Washington, D.C. office
Preferred
Familiarity with pharmaceutical and health policy, biopharmaceutical technologies, life sciences, medical product development, and legislative/regulatory processes is desirable
Company
Neurocrine Biosciences
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
Funding
Current Stage
Public CompanyTotal Funding
$260MKey Investors
Venrock
2015-02-19Post Ipo Equity· $250M
2009-12-17Post Ipo Equity· $10M
1996-05-31IPO
Recent News
BioWorld Financial Watch
2026-01-16
Company data provided by crunchbase